ebisoka
Some people would tell you that is was for us to "feel safe"
No, search for : Tangible Terror, Fear Object, Materialized Fear
As companies embrace tax-exemptions for company cars and people who get them are limited to choose EV only.
Free Government Regulated Capitalism.
Go to Main Page
Scroll down to go to the "Code of Conduct"
Search on "Reverse"
Read
"Our community prioritises marginalised people’s safety over privileged people’s comfort. Moderators reserve the right not to act on complaints regarding:
‘Reverse’ -isms, including ‘reverse racism,’ ‘reverse sexism,’ and ‘cisphobia.’ or critiques of racist, sexist, cissexist, or otherwise oppressive behaviors or assumptions."
Ask yourself if you want to be a part of a community of people that condones certain racism and sexism.
Who cares about the model when the owners are a bunch of racists and sexists, altough I guess some people who share these disgusting and regressive "values" will think it's great.
https://www.youtube.com/watch?v=L1mjG_F8ppw
another great site about CO2
"Authorized or approved mRNA COVID-19 vaccines show increased risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the lining outside the heart), particularly within the first week following vaccination."
https://www.pfizer.com/news/press-release/press-release-deta...
There was a recent study that it lowers the risk for diabetes with 15% when you have pre-diabetes. https://www.acpjournals.org/doi/10.7326/M22-3018
And Vitamin D also helps against Covid. https://c19early.org/dmeta.html
Vitamin K2 is the one for bone health
It was a late treatment study, and in the summary you can read "Late treatment and high dosages may be harmful”
The treatment study they did in my country had a result of 30% less dead.
But then came the obviously fake hcq study that was published in the lancet (lancetgate) that stopped all research into hcq, just think how many lives could have been saved otherwise.
HCQ for COVID-19 374 studies from 6,195 scientists 496,030 patients in 55 countries
Statistically significant improvement for mortality, hospitalization, recovery, cases, and viral clearance.
62%, 19% improvement for early and late treatment CI [52-70%], [14-23%]; 36, 247 studies
23% improvement in 8 early treatment RCTs CI [-20-51%]
72% less death in 15 early treatment trials CI [57-81%]